Clinical and Subclinical ACTH-Independent Macronodular Adrenal Hyperplasia and Aberrant Hormone Receptors
Authors:
- Isabelle BourdeauIBIsabelle Bourdeau
- André LacroixALAndré Lacroix
- 1 October 2005
- journal article
- review article
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 64 (3) , 119-131
Abstract
ACTH-independent macronodular adrenal hyperplasia (AIMAH) is a very rare cause of endogenous Cushing’s syndrome (CS). In this review, the clinical characteristics, the pathophysiology, and the management of AIMAH are described. AIMAH typically presents with overt CS, but subclinical oversecretion of cortisol has been increasingly described. The diagnosis is suspected by adrenal nodular enlargement on conventional imaging following the demonstration of ACTH-independent hypercortisolism. Final diagnosis is established by histological examination of the adrenal tissue. Bilateral adrenalectomy is the treatment of choice but unilateral adrenalectomy has been proposed in selected cases. In patients with subclinical CS, the decision to treat should be individualized. The pathophysiology of this condition has begun to be elucidated in recent years. Diverse aberrant membrane-bound receptors expressed in a non-mutated form in the adrenal gland have been found to be implicated in the regulation of steroidogenesis in AIMAH. When systematically screened, most patients with AIMAH and CS or subclinical CS exhibit an in vivo aberrant cortisol response to one or various ligands suggesting the presence of aberrant adrenal receptors. A protocol designed to screen patients for the presence of these aberrant receptors should be undertaken in all patients with AIMAH. The identification of these receptors provides the potential for novel pharmacological therapies by suppressing the endogenous ligands or blocking the receptor with specific antagonists.Keywords
This publication has 83 references indexed in Scilit:
- Leuprolide Acetate Therapy in Luteinizing Hormone–Dependent Cushing's SyndromeNew England Journal of Medicine, 1999
- Adrenocorticotropic Hormone-Independent Bilateral Adrenocortical Macronodular Hyperplasia Treated with Mitotane.Internal Medicine, 1999
- Propranolol Therapy for Ectopic β-Adrenergic Receptors in Adrenal Cushing's SyndromeNew England Journal of Medicine, 1997
- Regulation of Expression of ob mRNA and Protein by Glucocorticoids and cAMPJournal of Biological Chemistry, 1996
- Are activating mutations of the adrenocorticotropin receptor involved in adrenal cortical neoplasia?Life Sciences, 1995
- Localization of Steroidogenic Enzymes in Adrenal Cortex and Its Disorders.Endocrine Journal, 1994
- Adrenocorticotropic Hormone-Independent Bilateral Adrenocortical Macronodular Hyperplasia: A Case Report and Immunohistochemical Studies.Endocrine Journal, 1994
- Transition from Pituitary-Dependent to Adrenal-Dependent Cushing's SyndromeNew England Journal of Medicine, 1988
- Cushing syndrome, sexual precocity, and polyostotic fibrous dysplasia (Albright syndrome) in infancyThe Journal of Pediatrics, 1975
- McCune-Albright's syndrome following adrenalectomy for Cushing's syndrome in infancyThe Journal of Pediatrics, 1968